Correction to: Rheumatology International https://doi.org/10.1007/s00296-019-04503-5

In the Original article, the legend of Figs. 3 and 4 are interchanged and line number 387 is incomplete in the discussion section. The correct Figs. 3 and 4 legends and the complete sentence are given below:

Fig. 3
figure 3

Changes in macrovascular endothelial dysfunction (fow-mediated vasodilation) and von Willebrand factor antigen levels upon 12 weeks of adalimumab treatment in patients with early rheumatoid arthritis

Fig. 4
figure 4

Changes in time to half after hyperemia (TH2) of the postocclusive reactive hyperemia curve representing microcirculation upon 12 weeks of adalimumab treatment in patients with early rheumatoid arthritis

The complete line in the discussion section is “Our study may have important limitations. The limitations include the small number of patients in the second, pilot part of our study.”